The Vanguard Group Discloses Stake in Mural Oncology plc

The Vanguard Group, Inc. has released its disclosure regarding Mural Oncology plc under the Irish Takeover Panel Act of 1997, following Rule 8.3. The document, dated September 29, 2025, reveals that Vanguard, a major asset management firm, holds a 3.74% stake amounting to 646,568 of $0.01 ordinary shares in Mural Oncology.

The disclosure reports no short positions or involvement in cash-settled or stock-settled derivatives related to Mural Oncology's securities. A recent purchase within the disclosure period involved 32 ordinary shares at a price of 2.08 USD per unit.

Vanguard's document clarifies an absence of additional agreements or arrangements concerning these securities. No Supplemental Form 8 was included, indicating no further options or derivative dealings require reporting at this time.